Mato just raised pre-seed Read more
Podcast charts
Published by Robert Herriman
Interviews with expert guests on issues of infectious diseases, research, medicine and health.
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
The Mato Topic Intelligence Platform does not report this podcast as charting in a published category in this snapshot.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
In this news report, I look at the concerning situation in Japan with rising syphilis cases and a penicillin shortage.
In this news episode of Outbreak News Radio, I go over the latest measles news from Pennsylvania.
In this news episode, I look at the anthrax outbreak in Mpika District, Zambia.
A quick look at the dengue situation in Hillsborough County and the rest of Florida.
Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial resistant threats to public health worldwide. Clinicians expect to be confronted by rising rates of treatment failure in the years to come. As gonorrhea rates rise and treatment options become more limited, researchers are calling for a more tailored approach that combines new diagnostics, rapid resistance testing, surveillance and additional treatment options for the sexually transmitted disease. Joining me today to discuss drug-resistant gonorrhea is Dr. Lao-Tzu Allan-Blitz, Dr Allan-Blitz is an assistant professor in UCLA's David Geffen School of Medicine's Division of Infectious Diseases in the Department of Medicine, recently co-edited a supplement in the journal Clinical Infectious Diseases that outlines the threat and highlights recent advances in diagnostics and therapeutics that can help. Treatment Diversification to Address the Continued Rise of Antimicrobial Resistance in Neisseria gonorrhoeae
I look at outbreaks around the world over the past week from every continent: Ebola in DRC, malaria in DRC, Lassa in Nigeria, JE in Nepal, polio in Afghanistan, Legionnaires' disease in France, Sri Lanka dengue, Dengue in TampaBay, Florida and more.
In this news video, I go over the latest numbers from the Ebola Bundibugyo outbreak in the Democratic Republic of the Congo. In addition, I look at what some major health organizations, like MSF, WHO and Africa CDC, say about their concerns about the outbreak. Lastly, I offer some good news about some suspected cases that turned out negative very close to the capital city of Kinshasa.
Women who test positive for bacterial vaginosis (BV) were over three times more likely to also test positive for one or more non-viral sexually transmitted infections (STIs) than women who test negative for BV, according to a new Health Trends® study from Quest Diagnostics and Hologic, Inc., published in the journal Obstetrics and Gynecology Open. Joining me today to discuss the study and what healthcare providers should do based on this information is Beth Marlowe , PhD. Dr Marlowe is Executive Scientific Director and heads R&D for Quest Diagnostics Infectious Diseases and Immunology and co author of the study. Vaginitis and Sexually Transmitted Infections Coinfections
The first U.S. clinical trial of psilocybin-assisted therapy in veterans with PTSD who got no relief from conventional treatments has established that the protocol is safe, causing no serious adverse events or increases in suicidal thinking or behavior. In fact, the preliminary clinical results exceeded researchers' expectations. Joining me to discuss psilocybin-assisted therapy and PTSD and the study published in the journal Communications Medicine is Stacey Armstrong , PhD. Dr Armstrong is the Associate Director and Senior Researcher at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial
In this April 2014 interview, Daniel Pastula, MD, MHS, EIS Officer & Neurologist with CDC's Arboviral Diseases Branch discusses the new Heartland virus disease with Outbreak News This Week Radio Show host Robert Herriman
On today's show, I'll be looking at is very common medical problem- kidney stones- a problem so common that about 1 in 10 people in the United States suffer from them over their lifetime. Joining me today to discuss kidney stones is Carmin Kalorin, MD. Dr Kalorin is a board certified urologist from North Carolina and the author of the unique book, The Philosopher's Guide to Life, suffering and kidney stones , where he blends medical knowledge and ancient philosophy to help patients endure excruciating renal colic.
In this September 2013 radio interview, I talk to Jeremy Lewis of Kyle Cares Amoeba Awareness and Heidi LaMeyer of Swim Above Water, about their personal stories with the tragic deaths of their respective children and the work they were doing at their awareness organizations.
In a July 2013 interview on the Tampa-based, Outbreak News This Week radio show, I talk to Dr. Patricia Quinlisk, Iowa Dept. of Public Health Medical Director and State Epidemiologist, about the large cyclospora outbreak in Iowa and the midwest.
An active surveillance investigation is underway by the CDC, FDA and state health departments regarding a nationwide surge of cyclosporiasis cases, a parasitic infection. Dozens of states are affected, and of particular note, a massive spike of over 3,300 cases have been reported as of today. A single food source or supplier has not been definitively identified. Joining me today to discuss cyclospora and the outbreak is Wesley Long, MD, PhD. Dr Long is the medical director of microbiology at Houston Methodist.
Current Lyme disease tests look for antibodies produced by the immune system in response to Borrelia burgdorferi bacteria transmitted to humans by infected blacklegged ticks. My guest today says, "The problem is that these antibodies don't have the right characteristics to be clinically useful". New research led by Tufts University School of Medicine suggests that a group of immune molecules called anti-lipid antibodies may address these shortcomings. Joining me today do discuss this problem and the potential solution is Peter Gwynne, Phd. Dr Gwynne is a research assistant professor at Tufts University School of Medicine and the senior author of the new paper published in the journal, Infection and Immunity. Antiphospholipid antibodies in acute and post-treatment Lyme disease
In this newscast, I talk about the rapidly growing cyclospora outbreak in Michigan, especially in the southeast part of the state. I also talk about a little history of the parasite here in the US and go over some recommendations from health officials.
In a 2025 WHO report on global antibiotic resistance, they revealed that one in six bacterial infections worldwide in 2023 were completely resistant to standard antibiotic treatments. Between 2018 and 2023, antibiotic resistance increased in over 40% of the monitored pathogen-antibiotic combinations. The average annual increase in resistance sits between 5% and 15%. Bacterial AMR was directly responsible for an estimated 1.27 million global deaths in 2019 and contributed to 4.95 million deaths. Projections indicate that without massive interventions, deaths could surge by 70% by 2050, claiming nearly 10 million lives annually. Joining me today to discuss antibiotics, how they work, their history and antimicrobial resistance is Brenda A Wilson, PhD. Dr Wilson is a professor of microbiology and adjunct professor of pathobiology at the University of Illinois Urbana-Champaign. She is also the coauthor of the fantastic book, Revenge of the Microbes, 2nd ED
As tick populations grow and their ranges expand, the number of people being diagnosed with alpha-gal syndrome (AGS) is rising. So what is alpha gal syndrome? Today I want to dive into this serious, potentially life-threatening type of food allergy that is associated with the bite of a tick. Joining me today is Cara Martone, Cara is a doctoral student at Tufts University who is currently doing her research on AGS.
The New World screwworm has returned to the United States as the first case was reported in Texas on June 3, Since then, a number of additional cases have affected animals in Texas and New Mexico. What is the new world screwworm? How is it transmitted and how dangerous is it? And how will we get it under control? These are just a few of the questions I will pose to my expert guest. Joining me today is Lee Haines, Ph.D. Dr Haines is a medical entomologist and associate professor of Biological Sciences at the University of Notre Dame.
In this news report, I give an Ebola update, human screwworm in Honduras, measles in Bangladesh and Guatemala, hepatitis A in Manitoba, Canada and CCHF in Iraq.
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed September 12, 2026. Cached outside the daily freshness window; the positions keep the date they were taken on.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.